AU2021309548A1 - Inhibitors of complement factor C3 and their medical uses - Google Patents

Inhibitors of complement factor C3 and their medical uses Download PDF

Info

Publication number
AU2021309548A1
AU2021309548A1 AU2021309548A AU2021309548A AU2021309548A1 AU 2021309548 A1 AU2021309548 A1 AU 2021309548A1 AU 2021309548 A AU2021309548 A AU 2021309548A AU 2021309548 A AU2021309548 A AU 2021309548A AU 2021309548 A1 AU2021309548 A1 AU 2021309548A1
Authority
AU
Australia
Prior art keywords
compstatin
pharmaceutically acceptable
acceptable salt
compstatin analogue
sar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021309548A
Other languages
English (en)
Inventor
Rasmus LETH
Henrik Fischer MUNCH
Anne Pernille Tofteng SHELTON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zp Spv 3 K/s
Original Assignee
Zp Spv 3 K/s
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zp Spv 3 K/s filed Critical Zp Spv 3 K/s
Publication of AU2021309548A1 publication Critical patent/AU2021309548A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
AU2021309548A 2020-07-16 2021-07-15 Inhibitors of complement factor C3 and their medical uses Pending AU2021309548A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20186297 2020-07-16
EP20186297.6 2020-07-16
PCT/EP2021/069798 WO2022013374A1 (en) 2020-07-16 2021-07-15 Inhibitors of complement factor c3 and their medical uses

Publications (1)

Publication Number Publication Date
AU2021309548A1 true AU2021309548A1 (en) 2023-02-23

Family

ID=71661768

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021309548A Pending AU2021309548A1 (en) 2020-07-16 2021-07-15 Inhibitors of complement factor C3 and their medical uses

Country Status (11)

Country Link
US (1) US20230287051A1 (cg-RX-API-DMAC10.html)
EP (1) EP4182023A1 (cg-RX-API-DMAC10.html)
JP (1) JP2023538807A (cg-RX-API-DMAC10.html)
KR (1) KR20230039718A (cg-RX-API-DMAC10.html)
CN (1) CN116209671A (cg-RX-API-DMAC10.html)
AU (1) AU2021309548A1 (cg-RX-API-DMAC10.html)
CA (1) CA3185730A1 (cg-RX-API-DMAC10.html)
CO (1) CO2023001411A2 (cg-RX-API-DMAC10.html)
IL (1) IL299870A (cg-RX-API-DMAC10.html)
MX (1) MX2023000679A (cg-RX-API-DMAC10.html)
WO (1) WO2022013374A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020017385A2 (pt) 2018-02-27 2020-12-15 Zp Spv 3 K/S Análogos de compstatina, métodos e seus usos médicos
KR20240118914A (ko) 2021-01-20 2024-08-05 바이킹 테라퓨틱스 인코포레이티드 대사 및 간 질환 치료를 위한 조성물 및 방법
CA3231953A1 (en) 2021-09-15 2023-03-23 Brian Lian Compositions and methods for the treatment of metabolic and liver disorders
EP4622992A1 (en) * 2022-11-24 2025-10-01 Amyndas Pharmaceuticals US LLC Compstatin analogs for vector-based therapy
CN118812653A (zh) * 2023-04-18 2024-10-22 成都奥达生物科技有限公司 一种长效坎普他汀化合物
CN119219741A (zh) * 2023-06-29 2024-12-31 刘晓蓉 新型补体抑制剂及其制备、应用和产品
CN122255228A (zh) * 2024-12-20 2026-06-23 重庆派金生物科技有限公司 靶向抑制c3与c5补体的双功能多肽、多肽偶联物及它们的应用
US20260234189A1 (en) 2025-01-24 2026-08-13 Boehringer Ingelheim International Gmbh Novel and stable compstatin analogues

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000505068A (ja) 1996-03-13 2000-04-25 トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルベニア 補体活性化を阻害する新規ペプチド類
CZ295838B6 (cs) 1996-09-09 2005-11-16 Zealand Pharma A/S Způsob výroby peptidů
WO1999013899A1 (en) 1997-09-17 1999-03-25 Trustees Of The University Of Pennsylvania Peptides and peptidomimetics for inhibiting complement activation
US7989589B2 (en) 2002-09-20 2011-08-02 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved activity
CN101325963B (zh) 2005-10-08 2016-01-27 博泰迪亚制药公司 用于眼部病症的补体抑制素和其类似物
ES2390828T3 (es) 2005-11-28 2012-11-16 The Trustees Of The University Of Pennsylvania Análogos potentes de la compstatina
WO2008153963A1 (en) 2007-06-08 2008-12-18 The Trustees Of The University Of Pennsylvania Structure of compstatin-c3 complex and use for rational drug design
CA2813049A1 (en) * 2010-09-23 2012-03-29 The Trustees Of The University Of Pennsylvania Modified compstatin with improved stability and binding properties
EP2751161B1 (en) * 2011-08-31 2018-09-19 Huntsmann Advanced Materials Licensing (Switzerland) GmbH Process for the impregnation of air core reactors, impregnated air core reactor and use of an impregnation system
PL2753636T3 (pl) 2011-09-07 2020-05-18 The Trustees Of The University Of Pennsylvania Analogi kompstatyny o ulepszonych właściwościach farmakokinetycznych
WO2014100407A1 (en) 2012-12-19 2014-06-26 The Regents Of The University Of California Compstatin analogs
US10213476B2 (en) * 2014-03-17 2019-02-26 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved potency and pharmacokinetic properties
BR112020017385A2 (pt) * 2018-02-27 2020-12-15 Zp Spv 3 K/S Análogos de compstatina, métodos e seus usos médicos
ES3049784T3 (en) * 2019-08-27 2025-12-18 Zp Spv 3 K/S Compstatin analogues and their medical uses

Also Published As

Publication number Publication date
US20230287051A1 (en) 2023-09-14
CA3185730A1 (en) 2022-01-20
EP4182023A1 (en) 2023-05-24
MX2023000679A (es) 2023-04-18
CO2023001411A2 (es) 2023-02-16
CN116209671A (zh) 2023-06-02
JP2023538807A (ja) 2023-09-12
KR20230039718A (ko) 2023-03-21
WO2022013374A1 (en) 2022-01-20
IL299870A (en) 2023-03-01

Similar Documents

Publication Publication Date Title
US12600749B2 (en) Compstatin analogues and their medical uses
US20230287051A1 (en) Inhibitors of complement factor c3 and their medical uses
JP7819087B2 (ja) インターロイキン-23受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用
JP7711044B2 (ja) コンプスタチン類似体及びその医学的使用
CN107206254B (zh) 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途
CA2931694A1 (en) Fatty acid derivatives of dimeric peptide ligands of psd-95 and use thereof for treating excitotoxic disease
EA051613B1 (ru) Ингибиторы фактора с3 системы комплемента и варианты их применения в медицине
US10421785B2 (en) Delta receptor agonist peptides and use thereof
HK40102364B (en) Compstatin analogues and their medical uses
HK40102364A (en) Compstatin analogues and their medical uses
HK40092906A (en) Inhibitors of complement factor c3 and their medical uses
EA049126B1 (ru) Аналоги компстатина и пути их медицинского применения
HK1227702B (en) Novel polypeptides